TargetMol

Lisuride maleate

Product Code:
 
TAR-T8775
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8775-5mg5mg£571.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Lisuride maleate is an agonist of Dopamine receptor and anti-Parkinson's agent.?Displays high affinity for D2, D3 and D4 receptors along with 5-HT1A.?Exhibits some 5-HT2B receptor antagonist properties.?Decreases prolactin release;?reduces inflammatory mediators such as TNF-α and IL6.?Exhibits anticonvulsive effects.?Acts similar to bromocriptine
CAS:
19875-60-6
Formula:
C20H26N4O.C4H4O4.?H2O
Molecular Weight:
459.02
Purity:
0.98
SMILES:
0

References

Hofmann C , Penner U , Dorow R , et al. Lisuride, a dopamine receptor agonist with 5-HT2B receptor antagonist properties: absence of cardiac valvulopathy adverse drug reaction reports supports the concept of a crucial role for 5-HT2B receptor agonism in cardiac valvular fibrosis.[J]. Clinical Neuropharmacology, 2006, 29(2):80-86. Zweckberger K , Simunovic F , Kiening K L , et al. Anticonvulsive effects of the dopamine agonist lisuride maleate after experimental traumatic brain injury.[J]. Neuroscience Letters, 2010, 470(2):150-154. Jiang K, Liu X, Su R. Contrasting effects of DOI and lisuride on impulsive decision-making in delay discounting task. Psychopharmacology. 2022: 1-15. Zhu H, Liu X, Wang X, et al.G?? subunit inhibitor decreases DOM-induced head twitch response via the PLC?/IP3/Ca2+/ERK and cAMP signaling pathways.European Journal of Pharmacology.2023: 176038.